These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10661749)

  • 1. Pushing the frontiers of science--the Population Council's Microbicide Basic Science Network on vaginal microbicide research.
    Johansson ED; Maguire RA; Phillips DM
    Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S117-24. PubMed ID: 10661749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promise of public/private sector collaboration in the development of vaginal microbicides.
    Gabelnick HL; Harper MJ
    Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S31-8. PubMed ID: 10661739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbicide preference among young women in California.
    Holt BY; Morwitz VG; Ngo L; Harrison PF; Whaley KJ; Pettifor A; Nguyen AH
    J Womens Health (Larchmt); 2006 Apr; 15(3):281-94. PubMed ID: 16620187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model for collaboration: the alliance for microbicide development.
    Harrison PF
    Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S39-53. PubMed ID: 10661740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women's interest in vaginal microbicides.
    Darroch JE; Frost JJ
    Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Educating men about vaginal microbicides: considerations from Kenya.
    Gitome SW; Kwena ZA; Harper CC; Cohen CR; Bukusi EA
    Cult Health Sex; 2020 Jun; 22(6):660-674. PubMed ID: 31241426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk women's willingness to try a simulated vaginal microbicide: results from a pilot study.
    Mosack KE; Weeks MR; Novick Sylla L; Abbott M
    Women Health; 2005; 42(2):71-88. PubMed ID: 16537301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "We have our protector": misperceptions of protection against HIV among participants in a microbicide efficacy trial.
    Mantell JE; Morar NS; Myer L; Ramjee G
    Am J Public Health; 2006 Jun; 96(6):1073-7. PubMed ID: 16670239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women's preferences for vaginal antimicrobial contraceptives. V: attitudes of Brazilian women to the insertion of vaginal products.
    Hardy E; de Pádua KS; Hebling EM; Osis MJ; Zaneveld LJ
    Contraception; 2003 May; 67(5):391-5. PubMed ID: 12742563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unacceptable side-effects associated with a hyperosmolar vaginal microbicide in a phase 1 trial.
    Lacey CJ; Woodhall S; Qi Z; Sawant S; Cowen M; McCormack S; Jiang S
    Int J STD AIDS; 2010 Oct; 21(10):714-7. PubMed ID: 21139151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Men's attitudes towards a potential vaginal microbicide in Zimbabwe, Mexico and the USA.
    Coggins C; Blanchard K; Friedland B
    Reprod Health Matters; 2000 May; 8(15):132-41. PubMed ID: 11424261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges of introducing vaginal microbicides in India.
    Joshi S; Kulkarni V; Paranjape R; Chandhiok N
    Indian J Med Res; 2009 May; 129(5):618-9. PubMed ID: 19675395
    [No Abstract]   [Full Text] [Related]  

  • 13. Observations from the CDC. The urgent need for new HIV/STD prevention options for women.
    Irwin K; Scarlett M; Moseley R
    J Womens Health; 1998 Nov; 7(9):1081-6. PubMed ID: 9861583
    [No Abstract]   [Full Text] [Related]  

  • 14. Microbicide acceptability among high-risk urban U.S. women: experiences and perceptions of sexually transmitted HIV prevention.
    Weeks MR; Mosack KE; Abbott M; Sylla LN; Valdes B; Prince M
    Sex Transm Dis; 2004 Nov; 31(11):682-90. PubMed ID: 15502677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Female controlled methods of contraception and sexually transmitted infections including HIV in Malawi: examining the role of the female condom and microbicides.
    Bisika T
    East Afr J Public Health; 2009 Aug; 6(2):223-5. PubMed ID: 20000034
    [No Abstract]   [Full Text] [Related]  

  • 16. Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women.
    Olsen ML; Cwiak CA; Koudelka C; Jensen JT
    Contraception; 2007 Oct; 76(4):314-8. PubMed ID: 17900444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal microbicides and teenagers.
    Rupp RE; Rosenthal SL
    Curr Opin Obstet Gynecol; 2003 Oct; 15(5):371-5. PubMed ID: 14501239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The slow evolution of microbicides for STD/HIV prevention.
    Howes J; Bass M
    J Gend Specif Med; 1999; 2(3):22-3. PubMed ID: 11252848
    [No Abstract]   [Full Text] [Related]  

  • 19. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
    Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Easing the way to safer sex.
    Larkin M
    Lancet; 1998 Mar; 351(9107):964. PubMed ID: 9734955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.